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ABSTRACT: The synthesis of constrained spirocycles is achieved effectively by means of 1,3-dipolar cyclodditions employing α-
imino γ-lactones as azomethine ylide precursors and nitroalkenes as dipolarophiles. The complex formed by (R,R)-Me-DuPhos 18 
and AgF is the most efficient bifunctional catalyst. Final spiro-nitroprolinates cycloadducts are obtained in good to moderate yields 
and both high diastereo- and enantioselections.  Density functional theory (DFT) calculations supported the expected absolute con-
figuration as well as other stereochemical parameters.  
The importance of having a wide number of enantiomerically 
enriched sterically congested polysubstituted organic com-
pounds is continuously increasing. Many scientific areas need 
all these functionalized structures for their specialized research-
es. Along this line, optically active polysubstituted nitropro-
linates have emerged since 2005 as promising therapeutic 
agents.1 For example, molecules 1 (Figure 1) are important 
inhibitors of 41-integrin-mediated hepatic melanoma and in a 
murine model of colon carcinoma metastasis, as well as potent 
antiadhesive properties in several cancer cell lines.2,3 Bicyclic 
heterocycles 2, containing an atropane scaffold have been found 
as novel inhibitors of skin cancer.4 Spirooxindoles 3 increased 
the mortality of zebrafish embryos5 whilst molecules 4 with 
benzopyran skeleton were successfully tested as antimycobacte-
rials against M. tuberculosis H37Rv strain.6 Besides, the most 
simple 4-nitroprolines exo-5, and endo-6 have been recently 
used as chiral organocatalysts in aldol reactions.7 Michael-type 
addition of ketones to nitroalkenes was successfully run in the 
presence of exo-5b (X=H),8 obtaining good to excellent dia-
stereoselections and high enantiomeric ratios. A family of enan-
tiopure tetrasubstituted nitroprolinate surrogates has been de-
signed as scaffolds for proteasome inhibitors with high medici-
nal prospects.9 In addition, the NH-D-EhuPhos ligand 6 has 
been efficiently employed in the 1,3-dipolar cycloadditions 
(1,3-DC)10 to yield nitroprolines and structurally rigid spiro-
compounds from chiral γ-lactams.11,12   
Grigg and co-workers reported in 2008 the silver-promoted 
racemic and diastereoselective 1,3-DC involving homoserine 
derived imino esters 713 and nitroalkenes 8 obtaining spirolac-
tones 9 as major products (Scheme 1).14 The asymmetric ap-
proach to this molecules was performed by the employment of 
organocatalysts. Michael adducts could be isolated in a first 
step. A second treatment with DBU afforded enantiomerically 
enriched endo-cycloadducts 9 in good yields.15 These homoser-
ine-lactone surrogates are a class of signaling molecules in-
volved in the so called bacterial quorum sensing.16  
 
 
 
Figure 1. Nitroprolinates with synthetic or biological applications. 
 
Scheme 1. Racemic 1,3-DC between iminolactones 7 and nitroalkenes 8. 
 
 
In this work, with the idea of combining structural rigidity 
and enantiomerically enriched nitroprolinates, we report the 
direct enantioselective synthesis of these attractive intermedi-
ates 9.17,18,19 
For the optimization of the reaction privileged ligands20 11-
20 were tested in the silver-catalyzed 1,3-DC between imino 
lactone 7a and β-nitrostyrene 8a. Although we used L-
homoserine lactone as starting material to prepare dipole pre-
cursors 9, the chiral information contained in these compounds 
is not relevant (vide infra).  (S)-Segphos 13, (S)-Binap 10 and 
 its derivatives 11 and 12 afforded very low enantiomeric ratios 
(although high diastereoselectivity) of the major endo-
cycloadduct ent-9aa AgTfa (Tfa = trifluoroacetate) and AgF21 
being the most appropriate silver(I) salts (Table 1, entries 1-6). 
Then, phosphoramidites 14-17 were next evaluated. When the 
reaction was run in the absence of triethylamine using the 
(Ra,S,S)-14·AgF complex better results were recorded (Table 1, 
entries 7 and 8). Another silver salts in combination with phos-
phoramidite 14,  useful in other 1,3-DC with nitroalkenes,22 
such as AgOTf, AgOBz, and AgOAc and Ag2CO323 were as-
sayed but never improved the results obtained with AgF (Table 
1, entries 9-15). Other phosphoramidites 15-17 gave poor enan-
tioselectivities (Table 1, entries 13-15).  However, (R,R)-Me-
DuPhos 18·AgF complex furnished endo-9aa in 99:1 dr and 
86:14 er. Chiral ferrocenyl ligands 19 and 20 did not give better 
results (Table 1, entries 16-18). The effect of the temperature 
was considered and the enantiomeric ratio could be increased 
up to 90:10 when the reaction was performed at 0 ºC rather than 
when the reaction was carried out at -20 ºC (Table 1, entries 19 
and 20). It is remarkable the high endo:exo ratio achieved in 
entry 16 of Table 1 (99:1) versus the 3:1 reported in the litera-
ture for the racemic mixture.14 
 
Table 1. Optimization of reaction conditions of 1,3-DC of 7a and 8a 
 
 
en. ligand AgX base conv (%)a endo:exoa erb,c 
1 (S)-10 AgTfa TEA >98 93:7 45:55 
2 (S)-10 AgF TEA >98 89:11 45:55 
3 (S)-10 AgTfac TEA >98 93:7 36:64 
4 (S)-11 AgF TEA >98 96:4 50:50 
5 (S)-12 AgF TEA >98 98:2 31:69 
6 (S)-13 AgF TEA >98 98:2 20:80 
7 (Ra,S,S)-14 AgF TEA >98 88:12 73:27 
8 (Ra,S,S)-14 AgF 
___ >98 90:10 78:22 
9 (Ra,S,S)-14 AgOTf 
___ >95 84:16 66:34 
10 (Ra,S,S)-14 AgOBz 
___ >98 91:9 65:35 
11 (Ra,S,S)-14 AgOAc 
___ >98 86:14 66:34 
12 (Ra,S,S)-14 Ag2CO3 
___ >98 92:8 70:30 
13 (Sa,R,R)-15 AgF 
___ >98 76:24 36:64 
14 (R)-16 AgF ___ >98 99:1 70:30 
15 17 AgF ___ >95 92:8 37:63 
16 (R,R)-18 AgF ___ >95 99:1 86:14 
17 19 AgF ___ >95 79:21 66:34 
18 20 AgF ___ >20 ___ ___ 
19 (R,R)-18 AgFd ___ >95 99:1 90:10 
20 (R,R)-18 AgFe ___ >90 99:1 88:12 
a Determined by 1H NMR of the crude reaction mixture. b Determined by 
HPLC using chiral coated columns, endo-9aa:ent-9aa er. c Reaction per-
formed at -50 ºC during 50 h. d Reaction performed at 0 ºC during 50 h. 
e Reaction performed at -20 ºC. 
 
The possible structure of the catalyst involved in the process 
was studied. For a 1:1 mixture of (R,R)-Me-DuPhos 18 and 
AgF, 31PNMR experiment (in deuterated chloroform) revealed 
two doublets at 22.66 ppm (JAg109 = 256 Hz and JAg107 = 222 
Hz) and ESI-MS afforded a M+ = 719 corresponding to 
(18)2·Ag cluster. Analogous 
31P NMR and ESI-MS spectra 
were recorded when a 2:1 mixture of (R,R)-Me-DuPhos 18 and 
AgF was prepared. Another 31PNMR experiment was per-
formed by addition of 7a to the preformed 1:1 complex (R,R)-
Me-DuPhos 18:AgF but no signals were detected at all. At this 
point, we performed the reaction of the entry 16 of the Table 1 
with the (18)2·AgF complex generated in situ. The reaction was 
very slow and almost racemic endo-9aa was obtained with less 
than 5% conversion after 1 d.  
The scope of the reaction was next investigated. The (R,R)-
Me-DuPhos 18 and AgF24 were mixed and stirred for 30 min 
and the imino ester 7 was added at 0 ºC followed by the nitroal-
kene 8. Unsubstituted and 2, 3, or 4-substituted aryl groups of 
the nitrostyrene molecule afforded in relative good yields (45-
54%) 9ac-ae cycloadducts with high diastereoselectivity and 
moderate to high enantiomeric ratios (Table 2, entries 1-4). 2-
Furyl derivative 8e and alkyl substituted nitroalkenes 8f-g af-
forded higher er and good chemical yields with modest dia-
stereoselection (Table 2, entries 5-7). In these examples run 
with alkylated nitroolefins, the diastereoselection was higher 
than the 1:1 obtained in the literature.14 A modification of the 
aryl group of imino lactone 7 gave, in general similar chemical 
yields, and higher both diastereomeric and enantiomeric ratios 
of products 9 (Table 2, entries 8-15). 2-Methylphenyl surrogate 
7b was also an appropriate precursor giving 9ba as only one 
diastereoisomer although with a low enantiomeric ratio (80:20, 
Table 2, entry 8). 
 
Table 2. Scope of the enantioselective 1,3-DC of 7 and nitroalkenes 8 
 
en. 7, Ar 8, R1 9 
yield 
(%)a 
endo/ 
exob 
erc,d 
1 7a,Ph 8a, Ph 9aa 65 99:1 90:10 
2 7a, Ph 8b, 4-FC6H4 9ab 45 99:1 80:20 
3 7a, Ph 8c, 2-BrC6H4 9ac 50 95:5 75:25 
4 7a, Ph 8d, 3-BrC6H4 9ad 54 95:5 95:5 
5 7a, Ph 8e, 2-Furyl 9ae 71 99:1 92:8 
6 7a, Ph 8f, Cy 9af 65 78:22 96:4 
7 7a, Ph 8g, Bui 9ag 68 74:26 93:7 
8 7b, 2-MeC6H4 8a, Ph 9ba 50 95:5 75:25 
9 7c, 3-MeC6H4 8a, Ph 9ca 73 95:5 93:7 
10 7d, 4-MeC6H4 8a, Ph 9da 51 99:1 93:7 
11 7e, 4-MeOC6H4 8a, Ph 9ea 52 97:3 94:6 
12 7f, 4-BrC6H4 8a, Ph 9fa 40 99:1 98:2 
13 7g, 2-Naphthyl 8a, Ph 9ga 45 99:1 93:7 
14 7h, 2-Furyl 8a, Ph 9ha 51 99:1 80:20 
a Isolated yield after purification (flash silica gel). b Determined by 1H NMR 
of the crude reaction mixture. c Determined by HPLC using chiral coated 
columns. d Values for compounds endo-9. 
 
Theoretical calculations within the density functional theory 
(DFT) framework25 were carried out in order to further assess 
 the origins of the observed enantio- and diastereoselectivity in 
the 1,3-DC of 7a and nitroalkene 8 catalyzed by (R,R)-
MeDuPhos 18·AgF. This latter computational method has been 
demonstrated to be an useful tool for the analysis of the stereo-
chemical outcome observed in 1,3-DC, especially in reactions 
catalyzed by chiral silver(I) complexes.19b,23b,26 Moreover, we 
demonstrated in previous works that the enantioselectivity 
stems from the coordination pattern in the azomethine ylide and 
the effective blockage of one of the prochiral faces by the chiral 
ligand in the initial reactive complex.27 
Our calculations on the initial N-metalated INT1 reactive 
complex show that the silver(I) atom presents a tetrahedral 
environment where coordination sphere is saturated by the 
carbonylic oxygen atom and the nitrogen atom of the azome-
thine ylide and the two phosphorous atoms of the ligand 18 (see 
Supporting Information). This coordination pattern implies an 
effective blockage of the (1Si,3Re) prochiral face, thus prompt-
ing the preferential formation of cycloadducts endo-9 and exo-9 
over its enantiomeric counterparts ent-endo-9 and ent-exo-9. At 
this stage the chiral information contained in the -amino--
butyrolactone moiety is destroyed because of the formation of 
the azomethine ylide. Therefore, any source of chiral infor-
mation relies on the chiral ligand (Figure 3). 
Exploration of the Gibbs free energy surface shows that these 
1,3-DC are not concerted but stepwise.28 The first step consists 
of a Michael-type nucleophilic attack on the ,-unsaturated 
nitro derivative to yield an intermediate INT2 that leads to 
formation of the corresponding cycloadduct by an intramolecu-
lar Mannich-like ring closure step. The main geometric features 
and relative energies of the stationary points corresponding to 
the first step of the 1,3-DC between 7a and nitroalkene 8a cata-
lyzed by (R,R)-MeDuPhos 18·Ag are gathered in Figure 2. 
Our results showed that TS1 and TS2, associated with the 
formation of cycloadduct endo-9 and its enantiomer ent-endo-9, 
are less energetic than TS3 and TS4 (associated with formation 
of exo-9 and ent-exo-9) due to a favorable Coulombic interac-
tion between the nitro moiety of 8 and the silver atom in the 
formers. This favorable interaction, associated with an endo 
approach, results in a theoretical diastereomeric endo-9:exo-9 
ratio of 99:1, which is in good agreement with the experimental 
results (Table 2, entry 1). Moreover, the effective blockage of 
the (1Si,3Re) prochiral face by the catalytic system is compati-
ble with the energetic difference of 1.8 kcal/mol between TS1 
and TS2. This difference in favor of TS1 is related to the lower 
energy required to deform the geometry of the complex formed 
by the chiral ligand 18 and the N-metalated azomethine ylide. 
This initial geometry is modified to that of the TS. In addition, 
this geometry change minimizes the TS steric repulsion be-
tween the incoming nitroalkene and the catalytic system. This 
computed energetic difference is associated with a theoretical er 
of 96:4, also in perfect agreement with the experimental evi-
dences.  
The complete reaction mechanism that yields the cycloadduct 
9aa was further analyzed. The main geometrical features of the 
second transition structure TS5 and the energetic profile are 
depicted in Figure 3. The computed Gibbs activation barrier 
associated with the second step was ca. 7 kcal/mol lower than 
that associated with the first step. However, formation of the 
major cycloadduct is slightly endergonic. Therefore, the final 
equilibrium is the driving force of the reaction because ensures 
the release of 9aa and the recovery of the reactive ylide com-
plex.   
 
 
 
Figure 2. Main geometric features and relative energies (in kcal/mol) of the 
computed transition structures associated with the first step of the reaction 
between 8 and azomethine ylide (R,R)-MeDuPhos-Ag·7a computed at the 
M06(PCM)/6-31G*&LanL2DZ//B3LYP(PCM)/6-31G* &LanL2DZ level 
of theory. Bond lengths are given in Å. Blue surfaces represent the solvent-
accessible surface with a probe radius of 1.9 Å. 
 
 
 
Figure 3. Main geometric features of the second transition structure and 
relative energies (in kcal/mol) of the profile associated with the reaction 
between 8 and azomethine ylide INT1 to yield 9aa computed at the 
M06(PCM)/6-31G*&LanL2DZ//B3LYP(PCM)/6-31G*&LanL2DZ level of 
theory. Bond lengths are given in Å.  
 
The relative configuration of major stereoisomers endo-9 de-
duced by NOE experiments and by correlation with the chemi-
cal shifts and coupling constants previously reported for the 
racemic products,14 were in agreement with the absolute con-
figuration revealed by both the most favored computed struc-
ture and by X-ray diffraction analysis of compound endo-9ga.29 
In conclusion, an efficient method for the synthesis of spi-
ranic cycloadducts endo-9 from α-imino γ-lactones has been 
achieved. (R,R)-MeDuPhos 18·AgF was the most efficient in 
acting as bifunctional catalyst because the fluoride is behaving 
 as base. The endo-diastereoisomers were obtained in both high 
enantiomeric and diastereomeric ratios. These endo-products 
are unusual in this type of cycloaddtitions promoted by chiral 
Lewis acids.30 DFT calculations resulted to be a crucial tool to 
clarify the absolute configuration of these cycloadducts, which 
was confirmed later by X-ray diffraction analysis.  
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